Publikationen

Tackling bureaucracy and reforming the tax and subsidy systems are necessary to improve the economic conditions and to reduce the high unemployment rate.

Economic growth is expected to accelerate in 2018 and 2019, due to higher oil prices, stronger external demand and the easing of fiscal consolidation.

Chemicals businesses dependent on raw materials imports are highly exposed to exchange rate volatility and the looming threat of trade restrictions.

Good short-term outlook for the chemicals sector, but Brexit poses a downside risk for businesses profitability and payment behaviour in the mid-term.

Indonesian pharmaceuticals sector growth is driven by a rising population and the roll-out of the government's universal healthcare insurance system.

Further growth expected, but businesses dependent on construction, construction materials and consumer durables still require particular attention.

Potential taxes on chemicals-related imports could find US chemicals businesses paying more for feedstocks and would negatively impact supply chains.

Sales growth in the pharmaceuticals and healthcare market is supported by a robust economic outlook and increasing private and public healthcare spending.

Payment delays have not increased in 2017, despite many businesses suffering from decreased liquidity due to higher import prices for commodities.

Payment behaviour in the Polish chemicals sector has been good over the past two years, and the number of non-payments and insolvencies has been low.